0001437749-13-007891.txt : 20130621 0001437749-13-007891.hdr.sgml : 20130621 20130621122124 ACCESSION NUMBER: 0001437749-13-007891 CONFORMED SUBMISSION TYPE: SC 13D/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20130621 DATE AS OF CHANGE: 20130621 GROUP MEMBERS: FRED KNOLL GROUP MEMBERS: KNOLL CAPITAL MANAGEMENT L.P. SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: AtheroNova Inc. CENTRAL INDEX KEY: 0001377053 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 201915083 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-82426 FILM NUMBER: 13926380 BUSINESS ADDRESS: STREET 1: 2301 DUPONT DRIVE, SUITE 525 CITY: IRVINE STATE: CA ZIP: 92612 BUSINESS PHONE: (949) 525-5471 MAIL ADDRESS: STREET 1: 2301 DUPONT DRIVE, SUITE 525 CITY: IRVINE STATE: CA ZIP: 92612 FORMER COMPANY: FORMER CONFORMED NAME: AtheroNova, Inc. DATE OF NAME CHANGE: 20100519 FORMER COMPANY: FORMER CONFORMED NAME: Trist Holdings, Inc. DATE OF NAME CHANGE: 20080103 FORMER COMPANY: FORMER CONFORMED NAME: LandBank Group Inc DATE OF NAME CHANGE: 20061002 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: EUROPA INTERNATIONAL INC CENTRAL INDEX KEY: 0001160586 IRS NUMBER: 000000000 FILING VALUES: FORM TYPE: SC 13D/A BUSINESS ADDRESS: STREET 1: 200 PARK AVENUE STREET 2: SUITE 3900 CITY: NEW YORK STATE: NY ZIP: 10166 BUSINESS PHONE: 2128087474 MAIL ADDRESS: STREET 1: 200 PARK AVENUE STREET 2: SUITE 3900 CITY: NEW YORK STATE: NY ZIP: 10166 SC 13D/A 1 europa20130620_sc13da.htm SCHEDULE 13D/A europa20130620_sc13d.htm

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

  

 

SCHEDULE 13D

 

(AMENDMENT NO. 1)*

 

Under the Securities Exchange Act of 1934

 

 

AtheroNova Inc.


(Name of Issuer)

 

Common Stock, par value $0.0001 per share


(Title of Class of Securities)

 

047438 106


(CUSIP Number)

 

Europa International, Inc.

c/o Knoll Capital Management, L.P.

1114 Avenue of the Americas, 45th Floor

New York, NY 10036

212-808-7474 


(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)

 

June 17, 2013


(Date of Event which Requires Filing of this Statement)

 

If the filing person has previously filed a statement on Schedule 13G to report the acquisition which is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1(e), 13d-1(f) or 13d-1(g), check the following box.

 

Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See Rule 13d-7 for other parties to whom copies are to be sent.

 

(Page 1 of 7)

 


*The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

 

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

 
 

 

 

CUSIP No. 047438 106

 

Page     2       of     7     

 

1

NAME OF REPORTING PERSON

 

 

Europa International, Inc.  

 

2

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (see Instructions)   

(a)

 

 

(b) 

 

 

 

3

SEC USE ONLY  

4

SOURCE OF FUNDS (see Instructions)  

 

 

WC  

 

5

CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)  

 

 

 

6

CITIZENSHIP OR PLACE OF ORGANIZATION  

 

British Virgin Islands

 

 

7

SOLE VOTING POWER

 

NUMBER OF

 

0

 

SHARES

8

SHARED VOTING POWER

 

BENEFICIALLY

 

6,844,305

 

OWNED BY EACH

9

SOLE DISPOSITIVE POWER

 

REPORTING

 

0

 

PERSON WITH

10

SHARED DISPOSITIVE POWER

 

 

 

6,844,305

 

11

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

6,844,305

12

CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (see Instructions)

 

 

 

13

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

 

 

15.8% (1)  

 

14

TYPE OF REPORTING PERSON (see Instructions)

 

 

CO  

 

 

(1) Based on a total of 38,659,782 shares of the issuer’s common stock outstanding as of May 6, 2013.

 

 
 

 

 

CUSIP No. 047438 106

 

Page     3       of     7     

 

1

NAME OF REPORTING PERSON

 

 

Knoll Capital Management, L.P.

 

2

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (see Instructions)   

(a)

 

 

(b) 

 

 

 

3

SEC USE ONLY  

4

SOURCE OF FUNDS (see Instructions)  

 

 

N/A

 

5

CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)  

 

 

 

6

CITIZENSHIP OR PLACE OF ORGANIZATION  

 

Delaware

 

 

7

SOLE VOTING POWER

 

NUMBER OF

 

0

 

SHARES

8

SHARED VOTING POWER

 

BENEFICIALLY

 

6,844,305

 

OWNED BY EACH

9

SOLE DISPOSITIVE POWER

 

REPORTING

 

0

 

PERSON WITH

10

SHARED DISPOSITIVE POWER

 

 

 

6,844,305

 

11

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

6,844,305

12

CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (see Instructions)

 

 

 

13

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

 

 

15.8% (1)  

 

14

TYPE OF REPORTING PERSON (see Instructions)

 

 

PN

 

 

 (1) Based on a total of 38,659,782 shares of the issuer’s common stock outstanding as of May 6, 2013. 

 

 
 

 

 

CUSIP No. 047438 106

 

Page     4       of     7     

 

1

NAME OF REPORTING PERSON

 

 

Fred Knoll

 

2

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (see Instructions)   

(a)

 

 

(b) 

 

 

 

3

SEC USE ONLY  

4

SOURCE OF FUNDS (see Instructions)  

 

 

N/A

 

5

CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)  

 

 

 

6

CITIZENSHIP OR PLACE OF ORGANIZATION  

 

USA

 

 

7

SOLE VOTING POWER

 

NUMBER OF

 

12,500

 

SHARES

8

SHARED VOTING POWER

 

BENEFICIALLY

 

6,844,305

 

OWNED BY EACH

9

SOLE DISPOSITIVE POWER

 

REPORTING

 

12,500

 

PERSON WITH

10

SHARED DISPOSITIVE POWER

 

 

 

6,844,305

 

11

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

6,856,805

12

CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (see Instructions)

 

 

 

13

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

 

 

15.8% (1)  

 

14

TYPE OF REPORTING PERSON (see Instructions)

 

 

IN

 

 

(1) Based on a total of 38,659,782 shares of the issuer’s common stock outstanding as of May 6, 2013.

 

 
 

 

 

This Schedule 13D/A (“Schedule 13D/A”) amends the following sections of the Schedule 13D filed with the Securities and Exchange Commission on April 17, 2013 (“Schedule 13D”).

 

Item 2. Identity and Background.

 

Item 2 of Schedule 13D is supplemented and amended by the information below.

 

The address for the Reporting Persons is c/o Knoll Capital Management, L.P., 5 East 44th Street, Suite 12, New York, NY 10017.

 

Item 3. Source and Amount of Funds or Other Consideration.

 

Item 3 of Schedule 13D is supplemented and amended by the information below.

 

Effective as of June 17, 2013, Europa waived the beneficial ownership cap included in certain outstanding convertible notes and warrants owned by Europa. As a result of such waiver, the Reporting Persons’ beneficial ownership now includes 696,266 shares of Common Stock issuable to Europa upon exercise of outstanding warrants as of June 17, 2013, and 3,947,195 shares of Common Stock issuable to Europa upon conversion of outstanding convertible notes as of June 17, 2013.

 

Item 4. Purpose of Transaction.

 

Item 4 of Schedule 13D is supplemented and amended by the information below.

 

Reference is made to the disclosure set forth under Item 3 of this Schedule 13D/A, which disclosure is incorporated herein by reference.

 

All of the shares of Common Stock beneficially owned by the Reporting Persons, and to which this Schedule 13D/A relates, are held as an investment.

 

Item 5. Interest in Securities of the Issuer.

 

Item 5 of Schedule 13D is supplemented and amended by the information below.

 

Reference is made to the disclosure set forth under Item 3 of this Schedule 13D/A, which disclosure is incorporated herein by reference.

 

As of June 17, 2013, Europa beneficially owned 6,844,305 shares of Common Stock, consisting of 2,200,844 shares of Common Stock held directly by Europa, 696,266 shares of Common Stock issuable to Europa pursuant to warrants exercisable within 60 days of June 17, 2013, and 3,947,195 shares of Common Stock issuable to Europa pursuant to convertible notes convertible within 60 days of June 17, 2013. Assuming a total of 38,659,782 shares of Common Stock outstanding as of May 6, 2013, as reported in the Company’s Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on May 10, 2013, Europa’s beneficial ownership constitutes approximately 15.8% of the shares of Common Stock issued and outstanding.

 

As of June 17, 2013, KCM beneficially owned 6,844,305 shares of Common Stock, consisting of 2,200,844 shares of Common Stock held directly by Europa, 696,266 shares of Common Stock issuable to Europa pursuant to warrants exercisable within 60 days of June 17, 2013, and 3,947,195 shares of Common Stock issuable to Europa pursuant to convertible notes convertible within 60 days of June 17, 2013, based on its power, shared with Europa, to vote and dispose of, or to direct the vote or disposition of, all such securities. Assuming a total of 38,659,782 shares of Common Stock outstanding as of May 6, 2013, as reported in the Company’s Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on May 10, 2013, KCM’s beneficial ownership constitutes 15.8% of the shares of Common Stock issued and outstanding. KCM disclaims such beneficial ownership except to the extent of its pecuniary interest therein.

 

 
Page 5 of 7

 

 

As of June 17, 2013, Knoll beneficially owned 6,856,805 shares of Common Stock, consisting of 2,200,844 shares of Common Stock held directly by Europa, 696,266 shares of Common Stock issuable to Europa pursuant to warrants exercisable within 60 days of June 17, 2013, and 3,947,195 shares of Common Stock issuable to Europa pursuant to convertible notes convertible within 60 days of June 17, 2013, based on his power, shared with Europa, to vote and dispose of, or to direct the vote or disposition of, all such securities, and 12,500 shares of Common Stock issuable to Knoll pursuant to options exercisable within 60 days of June 17, 2013. Assuming a total of 38,659,782 shares of Common Stock outstanding as of May 6, 2013, as reported in the Company’s Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on May 10, 2013, Knoll’s beneficial ownership constitutes 15.8% of the shares of Common Stock issued and outstanding. Knoll disclaims such beneficial ownership except to the extent of his pecuniary interest therein.

 

Transactions by the Reporting Persons in shares of Common Stock effected in the past 60 days are described in Item 3 above.

 

 
Page 6 of 7

 

 

SIGNATURE

 

 

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this Schedule 13D is true, complete and correct.

 

 

 

Europa International, Inc.

 

 

By:

Knoll Capital Management L.P.

 

 

 

Investment Manager

 

 

 

 

 

 

 

 

 

 

 

 

 

Dated: June 19, 2013

/s/ Fred Knoll

 

 

By:

Fred Knoll

 

 

Its:

President

 

 

 

 

Knoll Capital Management L.P.

 

 

 

 

 

 

 

 

 

 

 

 

 

Dated: June 19, 2013

/s/ Fred Knoll

 

 

By:

Fred Knoll

 

 

Its:

President

 

 

 

Dated: June 19, 2013

/s/ Fred Knoll

 

 

Fred Knoll

 

 

 

 

Page 7 of 7